The OMERACT Ultrasound Task Force - Advances and Priorities by D&apos et al.
The Journal of Rheumatology Volume 36, no. 8
 Advances and Priorities−−The OMERACT Ultrasound Task Force 
TERSLEV and RICHARD J. WAKEFIELD
JOUSSE-JOULIN, DAVID KANE, INGRID MOLLER, MARCIN SZKUDLAREK, LENE 
WOLFGANG A. SCHMIDT, PETER V. BALINT, GEORGE A.W. BRUYN, SANDRINE
BACKHAUS, HELEN I. KEEN, GURJEET KAELEY, HANS-RUDOLF ZISWEILER, 
FILIPPUCCI, INGRID MOLLER, CARLOS PINEDA, FREDERICK JOSHUA, MARINA
PHILIPPE AEGERTER, ANNAMARIA IAGNOCCO, JANE E. FREESTON, EMILIO 
MARIA-ANTONIETTA D'AGOSTINO, PHILIP G. CONAGHAN, ESPERANZA NAREDO,
 http://www.jrheum.org/content/36/8/1829
J Rheumatol 2009;36;1829-1832
 http://www.jrheum.org/cgi/alerts/etoc   
1. Sign up for our monthly e-table of contents 
 http://jrheum.com/subscribe.html   
2. Information on Subscriptions 
 Refer_your_library@jrheum.com   
3. Have us contact your library about access options 
 http://jrheum.com/reprints.html   
4. Information on permissions/orders of reprints 
in rheumatology and related fields. 
Silverman featuring research articles on clinical subjects from scientists working 
 is a monthly international serial edited by Earl D.The Journal of Rheumatology
 Journal of Rheumatology
The on October 31, 2016 - Published by www.jrheum.orgDownloaded from 
1829D’Agostino, et al: Advances of OMERACT US taskforce
Personal non-commercial use only. The Journal of Rheumatology Copyright © 2009. All rights reserved.
The OMERACT Ultrasound Task Force — Advances
and Priorities
MARIA-ANTONIETTA D’AGOSTINO, PHILIP G. CONAGHAN, ESPERANZA NAREDO, PHILIPPE AEGERTER,
ANNAMARIA IAGNOCCO, JANE E. FREESTON, EMILIO FILIPPUCCI, INGRID MOLLER, CARLOS PINEDA,
FREDERICK JOSHUA, MARINA BACKHAUS, HELEN I. KEEN, GURJEET KAELEY, HANS-RUDOLF ZISWEILER,
WOLFGANG A. SCHMIDT, PETER V. BALINT, GEORGE A.W. BRUYN, SANDRINE JOUSSE-JOULIN,
DAVID KANE, INGRID MOLLER, MARCIN SZKUDLAREK, LENE TERSLEV, and RICHARD J. WAKEFIELD
ABSTRACT. This article reports the most recent work of the OMERACT Ultrasound Task Force (post
OMERACT 8) and highlights of future research priorities discussed at the OMERACT 9 meeting,
Kananaskis, Canada, May 2008. Results of 3 studies were presented: (1) assessing intermachine reli-
ability; (2) applying the scoring system developed in the hand to other joints most commonly affect-
ed in rheumatoid arthritis (RA); and (3) assessing interobserver reliability on a deep target joint
(shoulder). Results demonstrated good intermachine reliability between multiple examiners, and
good applicability of the scoring system for the hand on other joints (including shoulder). Study con-
clusions were discussed and a future research agenda was generated, notably the further develop-
ment of a Global OMERACT Sonography Scoring (GLOSS) system in RA, emphasizing the impor-
tance of testing feasibility and added value over standard clinical variables. Future disease areas of
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Musculoskeletal ultrasound (US) is an increasingly utilized
method for the assessment and quantification of joint
inflammation and damage in rheumatoid arthritis (RA) and
other inflammatory arthritides. Despite its widespread use
in daily practice for helping clinicians make decisions about
patient care (e.g., change of diagnosis, monitoring of thera-
py efficacy or successful guidance of needles for aspiration
or injection)1,2, its use in research and therapeutic trials has
been hampered by a perception of observer dependence and
lack of validity.
PAST ACTIVITIES
In 2004 an international collaborative group of ultrasound
experts was formed to address the metric qualities of US
according to criteria specified by the OMERACT filter.
They met for the first time in Asilomar, CA, USA, at
OMERACT 7. A preliminary systematic review in the field
of inflammatory arthritis on a joint-by-joint basis was pre-
sented during that meeting3. This work underlined the lack
of published data about validity of US, especially for scan
acquisition and definitions. Based on these results, a future
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research agenda was agreed on. The first step was to obtain
preliminary consensus definitions for US-defined inflamma-
tory pathology4. A prerequisite for longitudinal multicenter
evaluation of responsiveness and predictive value of US is
that the measure is reproducible. Until 2004, US studies
have used joint pathology definitions, scanning techniques,
and scoring systems developed within individual centers.
Therefore, the evaluation of the reliability of the technique
was considered a priority of our group. Subsequently a num-
ber of mainly European-based projects were undertaken to
assess the reliability of US in inflammatory arthritis, but
with a particular focus on RA.
At OMERACT 8, held in Malta in 2006, the group pre-
sented work undertaken post OMERACT 7. This included
an overview of preliminary reliability exercises undertaken
between individuals and groups for detecting pathological
lesions (synovitis, erosions, tenosynovitis, and entheso-
pathy)5-7. Results of those exercises highlighted specific
problems of standardization of the acquisition and interpre-
tation of US images. Additional exercises undertaken in
Paris (December 2004 to December 2005), which focused
on metacarpophalangeal (MCP) joint synovitis in RA using
the established OMERACT definition, were also presented.
These iterative projects tested and retested interobserver and
intraobserver reliability for both interpretation and acquisi-
tion of images of the MCP joint, including newly introduced
semiquantitative grades8. During this exercise the same type
of machine was used. Intra- and interobserver reliability for
detecting and acquiring synovitis was assessed according to
standard κ-coefficient and weighted κ-coefficient with
absolute weighting [κ(w)] for semiquantitative grades.
K-coefficients were interpreted according to Landis and
Koch9. Results confirmed that the OMERACT US defini-
tions and consensus scoring system of synovitis combined
with a standardized acquisition protocol provided good
intra- and interobserver reliability (D’Agostino, et al, man-
uscript in preparation).
It was also apparent from this meeting that the following
areas needed further development. First, to test intermachine
reliability in particular for Doppler; second, to test whether
a minimal core set of joints could replace multiple joint
assessment in clinical practice and trials; and third, to assess
the sensitivity to change of US-detected synovitis, and the
predictive validity of US-detected synovitis with respect to
disease-centered (e.g., erosions) and patient-centered (e.g.,
function) outcomes.
OMERACT 9 Ultrasound Special Interest Group session. At
this session the results of activities post OMERACT 8 were
presented and future research priorities were discussed (see
below), and endorsed by OMERACT 9 participants.
1. Intermachine reliability exercise (Leeds, October
2007): In order to conclude the reliability exercises, we pre-
sented the results of an intermachine reliability study
involving multiple observers. Financial support for this
study was obtained by the EULAR Standing Committee for
International Clinical Studies Including Therapeutics
(ESCISIT) with a view to producing EULAR/OMERACT
recommendations.
The exercise focused on MCP joint synovitis and was
conducted using the same methodology and protocol of pre-
vious Paris exercises. At the consensus meeting held the day
before, it was decided to use the global scoring of synovitis
tested in Paris 2005 as well as a scoring for all single com-
ponents [power Doppler (PD) signal, effusion, and synovial
hypertrophy]. Four different machine types were utilized,
with the same sonographers who participated in the Paris
exercises. US examinations were performed using each
machine according to a Latin square design. Two rounds of
scanning occurred in order to assess the intraobserver and
intramachine reliability. The results varied according to the
machine used. According to Landis and Koch9, 2 of the 4
machines appeared to provide more reproducible results:
here κ-coefficients ranged from moderate (0.6) to good (0.8)
for both single lesions and global scoring (0.8). For the other
2 machines results were mitigated: they ranged from poor
(0.2) to moderate (0.5) for almost all of the lesions and scor-
ing. The results of this exercise confirmed the good reliabil-
ity among experts concerning the consensus of definitions
and scoring system obtained in the last Paris exercise, espe-
cially when a particular machine was used10.
2. Testing the definition and scoring system of synovitis
on other joints: The group’s initial studies were based on the
MCP joint, but the group decided to use the same method-
ology to assess other joints commonly involved in RA. In
particular, the focus would be on those joints used in other
disease activity scores (DAS, i.e., DAS28), and among these
are some potential index joints such as the wrist. Some
joints seem to be predictive of evolution and severity
(metatarsophalangeals) and some joints are very important
to the prognosis of disease; others are difficult to evaluate
and often paucisymptomatic (shoulder).
(a) Shoulder reliability exercise: A shoulder study was
conducted in Barcelona in June 2007 to compare US with
magnetic resonance imaging for the detection of inflamma-
tory and mechanical pathologies and to assess the intra- and
interobserver reliability of US for detecting those lesions.
Results of this exercise showed that the detection and scor-
ing of inflammatory lesions such as synovitis and erosions
were good, but underlined the difficulties for detecting and
scoring mechanical-related abnormalities such as rotator
cuff lesions11.
(b) Interjoint reliability exercise: During the Leeds exer-
cise (October 2007), an intra- and interobserver reliability
exercise on static images was also performed to test the
definition of synovitis and scoring systems for other joints.
Joints proposed and included in this step were as follows:
proximal interphalangeal, wrist, metatarsophalangeal, knee.
A scoring system was developed for the MCP joint for both
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single lesions (i.e., PD signal, effusion, and synovial hyper-
trophy) and global synovitis (i.e., PD + effusion + synovial
hypertrophy). Interobserver reliability results presented
ranged from good to excellent for both single lesions and
global synovitis, with a high agreement (κ-coefficient
superior to 0.7) for proposed global scoring for the MCP
joint (D’Agostino, et al12).
3. Development of an US joint count: The prospect of
developing an US joint count is attractive in that it might
potentially be able to more objectively reflect a global level
of synovitis and hence be more representative of disease
activity in RA patients than conventional clinical measures.
The results from a recently published multicenter longitudi-
nal study were presented that compared an US 44-joint
count with a number of reduced counts. It concluded that a
12-joint count was feasible and sensitive to change13.
However, the validity of this reduced joint count remains to
be confirmed in other multicenter longitudinal studies and
particularly in an early RA cohort.
CURRENT ACTIVITIES
Current group work. Based on all the iterative exercises per-
formed since 2004, the US group is currently developing
OMERACT/EULAR recommendations for detecting and
scoring synovitis in RA, including the production of an atlas
with representative images for different joints.
Several published studies underlined the sensitivity of
US above clinical examination1,2. However, no consensual
or validated scoring systems were used, making evaluation
of results and comparison of studies difficult. A multicenter
international study has, therefore, been planned to start at
the end of 2008 in order to test the sensitivity to change of
the OMERACT synovitis scoring system in multicenter
clinical trials.
FUTURE ACTIVITIES
Agenda. Considering the greater sensitivity of US over clin-
ical examination for detecting synovitis through the group
discussions and feedback sessions, the concept of develop-
ing an US-based global scoring system in RA was felt to be
important. Such a scoring system would be known as the
RA GLOSS system. This global US scoring system at
patient level would permit physicians to objectively follow
patients under treatment in clinical and research practice by
using a feasible and economical tool. However, emphasis
was placed on investigating its added value over existing
clinical measurements such as DAS28.
Interest in using US for evaluating other inflammatory or
degenerative pathologies has also grown recently. Although
the US features of peripheral joint pathology in spondy-
loarthritis (SpA) including psoriatic arthritis, osteoarthritis
(OA), and crystal-related pathologies have been described,
there is limited validity work and universally accepted semi-
quantitative scoring systems for outcome assessment. As
with RA, a number of scoring methods have been described,
with limited data on their psychometric properties. The US
group has, therefore, decided to focus on standardization of
enthesitis in SpA and joint-related pathologies in OA
(including osteophyte and cartilage). A similar approach to
the RA synovitis model will be used to assess other inflam-
matory and degenerative lesions seen on US. Preliminary
work on standardizing US enthesitis has already been per-
formed by some members of the group.
CONCLUSION
In summary, the group aims for continued improvement in
RA outcome measurement using US. To date it has been
successful in improving reliability of the technique and has
helped in dispelling the myth that US is too subjective. The
priority now is to test the credibility and responsiveness of
this technique in the context of clinical trials. In particular,
data about its added value over standard clinical measure-
ments is crucial. Based on results of the exercises and dis-
cussions at OMERACT 9, future research directions of the
group in RA include further validation of a global US scor-
ing system at the patient level with particular reference to
sensitivity to change and discrimination. At the same time a
proposed atlas of a RA synovitis scoring system for helping
ultrasonographers in their clinical daily practice is in
preparation.
The growth of ultrasound as an outcome measure in other
inflammatory diseases, such as SpA, provides scope for
applying the rigorous OMERACT methodology to these
conditions. Within the fields of SpA and OA, developing
definitions of important US pathological lesions, as well as
a standardized and reliable scoring system, will be the
priority in the preparation for OMERACT 10.
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Correction
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